EUCTR2005-001843-49-DE进行中（未招募）不适用
Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Substudy of P03802 - NA
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Subjects previously enrolled in protocol P03802 must have either:
- •a) successfully completed the 48-week phase,
- •b) been randomized to placebo and discontinued early because of
- •virologic failure or,
- •c) discontinued from P03802 because of a shift in tropism to R5/X4 mixed phenotype but had a good virologic response and no decrease in CD4 count from baseline.
- •Subjects must have acceptable hematologic, renal and hepatic laboratory values.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •History of recurrent seizure or CNS condition predisposing to seizure
- •Use of agents known to inhibit cytochrome P450 3A4 (eg, ritonavir, etc).
- •Use of agents agents known to induce cytochrome P450 3A4 (eg efavirenz, etc)
研究者
相似试验
已完成
2 期
Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100)HIVHIV InfectionsNCT00686829Merck Sharp & Dohme LLC79
进行中（未招募）
1 期
Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E1) - VICTOR-E1HIV infection (R5-tropism only) with previous therapyLevel: LLTClassification code 10200172EUCTR2005-001057-21-PTSchering-Plough Research Institute
进行中（未招募）
1 期
Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E1) - VICTOR-E1HIV infection (R5-tropism only) with previous therapyLevel: LLTClassification code 10200172EUCTR2005-001057-21-GBSchering-Plough Research Institute
进行中（未招募）
1 期
Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E2) - VICTOR-E2HIV infection (mixed X4/R5 torpism) with previous therapyLevel: LLT Classification code 10020172EUCTR2005-001058-26-PTSchering-Plough Research Institute500
进行中（未招募）
不适用
Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E2) - VICTOR-E2HIV infection (mixed X4/R5 torpism) with previous therapyLevel: LLTClassification code 10020172EUCTR2005-001058-26-DESchering-Plough Research Institute500